EADV Podcast

Join Prof. Rolland Gyulai as he presents his selection of Editor’s Picks from the June 2026 issue: 
 
First oral TNFR1 inhibitor for mild-to-moderate psoriasis
Adjuvant treatment with immune checkpoint inhibitors - no benefit in acral melanomas
Simple biomarkers predict favourable treatment response
Mogamulizumab-associated rash – new insights into pathogenesis
Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70448

In this episode of the EADV Podcast, Dr. Antonio Torrelo speaks with Dr. Andrea Diociaiuti, contributor to the recent JEACP Special issue on cutaneous mosaicism, to explore one of the most fascinating concepts in dermatology and genetics. Together, they discuss how mosaicism shapes the skin, the clinical patterns that help physicians recognise these conditions, and how advances in genetic sequencing are transforming diagnosis and patient care. The conversation also delves into the broader implications of mosaicism beyond the skin, the importance of careful clinical observation, and the increasing potential of precision medicine and targeted therapies. This episode offers listeners an accessible and forward-looking overview of a rapidly evolving field that is changing the way dermatologists understand genetics, skin biology, and personalised medicine.
 
Read the Special Issue: https://onlinelibrary.wiley.com/toc/27686566/2025/4/3
 

Join Prof. Carle Paul as he presents his selection of Editor’s Picks from the May 2026 issue: 
Management of cutaneous immune adverse events associated with immune check point inhibitors (ICI)
Pregnancy-associated melanoma: no additional risk of progression
Long-term treatment with nemolizumab for atopic dermatitis
Management of cutaneous lupus: state of the art
 
Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70409

In this episode of the EADV Podcast, Dr. Azael Freites Martinez is joined by Prof. Zoe Apalla and Dr. Vincent Sibaud for a practical discussion on the dermatologic adverse events associated with immune checkpoint inhibitors. Together, they explore why the skin is so commonly affected, how to recognise the most frequent reactions in daily practice, and when cancer patients should be referred to a dermatologist.
The conversation also highlights current management strategies for pruritus, eczematous, psoriasiform and lichenoid reactions, with a focus on accurate diagnosis, multidisciplinary collaboration, and the growing role of targeted and biologic therapies in supportive oncodermatology.
The episode closes with an important reminder: many of these skin reactions are manageable, and timely dermatologic care can make a meaningful difference to both quality of life and cancer treatment continuity.

Join Sarah Walsh as she presents her selection of Editor’s Picks from the April 2026 issue:
Robust data supporting biologics in paediatric psoriasis
Economically encouraging results for biologics in hidradenitis suppurativa
News about scabies and tips for ticks!
Pain control in SJS/TEN may protect against PTSD
 
Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70342

In this episode of the EADV Podcast, Dr. Sarah Walsh speaks with guest editors Prof. Jo Lambert and Prof. Curdin Conrad about the JEADV Special issue on Personalised Medicine.
They explore how dermatology is moving from trial-and-error treatment toward stratified and precision approaches, particularly in psoriasis and hidradenitis suppurativa, with the aim of delivering the right treatment to the right patient at the right time.
The discussion also addresses important challenges, including cost, accessibility, and health equity, offering a balanced and forward-looking perspective on how personalised medicine may reshape everyday clinical practice.
This episode offers an exploration of how personalised medicine is reshaping dermatology, scientifically, clinically, and ethically, and what it means for everyday patient care.

In this episode of the EADV Podcast, Prof. Dedee Murrell speaks with Prof. Carmen Salavastru, former Secretary General of the EADV, about her remarkable professional journey and her vision for the future of European dermatology.
From training in Bucharest to becoming one of the Academy’s key leaders, Prof. Salavastru reflects on how access to education, mentorship, and international collaboration shaped her career. The conversation explores her dual path in dermatology and physiology, her pioneering work linking skin and systemic disease, and the creation of national programmes for rare skin conditions.
They also discuss leadership, resilience, work–life balance, and the importance of expanding educational opportunities for dermatologists across Europe and beyond. The episode offers both inspiration and practical insight for clinicians at every stage of their career.

Join Prof. Carle Paul as he presents his selection of Editor’s Picks from the February 2026 issue:
Allogenic transplantation for advanced cutaneous T-cell skin lymphoma
Antifungal resistance of Trichophyton: insight from China
Stopping the progression of frontal fibrosing alopecia: the SOFFIA statement
Healthy lifestyle adoption to reduce the risk of late-onset psoriasis
 
Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70253